Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review

Rodd AL, Ververis K, Karagiannis TC. Current and emerging therapeutics for cutaneous T-cell lymphoma: histone deacetylase inhibitors. Lymphoma. 2012;16(2012):1–10.

Google Scholar 

Kempf W, Mitteldorf C. Cutaneous T-cell lymphomas—an update 2021. Hematol Oncol. 2021;39(S1):46–51.

Article  CAS  Google Scholar 

Kirsch IR, Watanabe R, O’Malley JT, Williamson DW, Scott L, Elco CP, et al. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med. 2015;7(308):308ra158.

Article  Google Scholar 

Peterson E, Weed J, Lo Sicco K, Latkowski JA. Cutaneous T cell lymphoma: a difficult diagnosis demystified. Dermatol Clin. 2019;37(4):455–69.

Article  CAS  Google Scholar 

Weed J, Girardi M. The difficult–and often delayed–diagnosis of CTCL. Sci Transl Med. 2015;7(308):308fs41.

Article  Google Scholar 

Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome. Arch Dermatol. 2003;139(7).

Lozano A, Duvic M. Cutaneous T-cell lymphoma in non-blood-related family members: report of an additional case. J Am Acad Dermatol. 2007;56(3):521.

Article  Google Scholar 

Hazen PG, Michel B. Hodgkin’s disease and mycosis fungoides in a married couple. Dermatologica. 1977;154(5):257–60.

Article  CAS  Google Scholar 

Triantafyllopoulou I, Nikolaou V, Marinos L, Papadaki T, Antoniou C. Tumor stage mycosis fungoides in nonblood-related family members. J Am Acad Dermatol. 2014;71(5):1001–2.

Article  Google Scholar 

Morales-Suárez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guénel P, Arveux P, et al. Occupational sun exposure and mycosis fungoides: a European multicenter case-control study. J Occup Environ Med. 2006;48(4):390–3.

Article  Google Scholar 

Meibodi N, Ghazvini K, Esmaily H, Hesamifard M, Nahidi Y. Evaluation of the association between epstein-barr virus and mycosis fungoides. Indian J Dermatol. 2015;60(3):321.

Article  Google Scholar 

Jumbou O, Mollat C, N’Guyen JM, Billaudel S, Litoux P, Dréno B. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients. Br J Dermatol. 1997;136(2):212–6.

CAS  Google Scholar 

Herne KL, Talpur R, Breuer-McHam J, Champlin R, Duvic M. Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome. Blood. 2003;101(6):2132–6.

Article  CAS  Google Scholar 

Schmidt AN, Robbins JB, Greer JP, Zic JA. Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2006;54(5 Suppl):S202–5.

Article  Google Scholar 

Jackow CM, McHam JB, Friss A, Alvear J, Reveille JR, Duvic M. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. J Invest Dermatol. 1996;107(3):373–6.

Article  CAS  Google Scholar 

Jahan-Tigh RR, Huen AO, Lee GL, Pozadzides JV, Liu P, Duvic M. Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series. Cancer. 2013;119(4):825–31.

Article  CAS  Google Scholar 

Bobrowicz M, Fassnacht C, Ignatova D, Chang Y, Dimitriou F, Guenova E. Pathogenesis and therapy of primary cutaneous T-cell lymphoma: collegium internationale allergologicum (CIA) upd ate 2020. Int Arch Allergy Immunol. 2020;181(10):733–45.

Article  CAS  Google Scholar 

Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91(1):151–65.

Article  CAS  Google Scholar 

da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, et al. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. Nat Genet. 2015;47(12):1465–70.

Article  Google Scholar 

Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 2015;47(9):1011–9.

Article  CAS  Google Scholar 

Bastidas Torres AN, Cats D, Mei H, Szuhai K, Willemze R, Vermeer MH, et al. Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides. Genes Chromosomes Cancer. 2018;57(12):653–64.

Article  CAS  Google Scholar 

Park J, Yang J, Wenzel AT, Ramachandran A, Lee WJ, Daniels JC, et al. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). Blood. 2017;130(12):1430–40.

Article  CAS  Google Scholar 

Wilson LD, Hinds GA, Yu JB. Age, race, sex, stage, and incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk. 2012;12(5):291–6.

Article  Google Scholar 

Martinez-Escala ME, Posligua AL, Wickless H, Rutherford A, Sable KA, Rubio-Gonzalez B, et al. Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol. 2018;78(6):1068–76.

Article  Google Scholar 

Moustou A, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ. Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review. J Am Acad Dermatol. 2009;61(3):486–504.

Article  CAS  Google Scholar 

Trum NA, Zain J, Abad C, Rosen ST, Querfeld C. Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash. JAAD Case Reports. 2021;14:37–42.

Article  Google Scholar 

Steck O, Bertschi NL, Luther F, van den Berg J, Winkel DJ, Holbro A, et al. Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndrome. J Eur Acad Dermatol Venereol. 2021;35(6):1331–7.

Article  CAS  Google Scholar 

Mahé E, Descamps V, Grossin M, Fraitag S, Crickx B. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. Br J Dermatol. 2003;149(1):170–3.

Article  Google Scholar 

Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, et al. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J Am Acad Dermatol. 2004;51(4):660–2.

Article  Google Scholar 

Dalle S, Balme B, Berger F, Hayette S, Thomas L. Mycosis fungoides-associated follicular mucinosis under adalimumab. Br J Dermatol. 2005;153(1):207–8.

Article  CAS  Google Scholar 

Berthelot C, Cather J, Jones D, Duvic M. Atypical CD8+ cutaneous T-cell lymphoma after immunomodulatory therapy. Clin Lymphoma Myeloma. 2006;6(4):329–32.

Article  Google Scholar 

Dauendorffer J, Rivet J, Allard A, Bachelez H. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis. Br J Dermatol. 2007;156(4):742–3.

Article  CAS  Google Scholar 

Koens L, Senff NJ, Vermeer MH, Ronday HK, Willemze R, Jansen PM. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis. Acta Derm Venereol. 2009;89(6):653–4.

Article  Google Scholar 

Lafaille P, Bouffard D, Provost N. Exacerbation of undiagnosed mycosis fungoides during treatment with etanercept. Arch Dermatol. 2009;145(1):78.

Article  Google Scholar 

Lees CW, Ali AI, Thompson AI, Ho GT, Forsythe RO, Marquez L, et al. The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up. Aliment Pharmacol Ther. 2009;29(3):286–97.

Article  CAS  Google Scholar 

Michot C, Costes V, Gerard-Dran D, Guillot B, Combes B, Dereure O. Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis. Br J Dermatol. 2009;160(4):889–90.

Article  CAS  Google Scholar 

Bittencourt AL, Oliveira PD, Bittencourt VG, Carvalho EM, Farre L. Adult T-cell leukemia/lymphoma triggered by adalimumab. J Clin Virol. 2013;58(2):494–6.

Article  CAS  Google Scholar 

Papp K, Griffiths C, Gordon K, Lebwohl M, Szapary P, Wasfi Y, et al. Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol. 2013;168(4):844–54.

Article  CAS  Google Scholar 

Jacks SM, Taylor BR, Rogers RP, Ralston JS, Metcalf JS, Lazarchick J. Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti’) lymphoma after administration of adalimumab. J Am Acad Dermatol. 2014;71(3):e86–7.

Article  Google Scholar 

Suga H, Sugaya M, Toyama T, Sumida H, Fujita H, Kogure A, et al. A case of mycosis fungoides with large cell transformation associated with infliximab treatment. Acta Derm Venereol. 2014;94(2):233–4.

Article  Google Scholar 

Ma H, Qiu S, Lu R, Feng P, Lu C. Methotrexate and etanercept-induced primary cutaneous CD4 positive small/medium-sized pleomorphic T-cell lymphoma. An Bras Dermatol. 2016;91(3):368–71.

Article  Google Scholar 

DʼHaens G, Reinisch W, Panaccione R, Satsangi J, Petersson J, Bereswill M, et al. Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry. Am J Gastroenterol. 2018 06;113(6):872-82.

Chiba T, Nagai T, Osada SI, Manabe M. Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis. Acta Derm Venereol. 2019;99(9):818–9.

Article  Google Scholar 

Partarrieu-Mejías F, Díaz-Corpas T, Pérez-Ferriols A, Alegre-de MV. Mycosis fungoides after treatment with tumor necrosis factor-alpha inhibitors for psoriasis: progression or onset. Int J Dermatol. 2019;58(5):e103–5.

Article  Google Scholar 

Espinosa ML, Nguyen MT, Aguirre AS, Martinez-Escala ME, Kim J, Walker CJ, Pontes DS, Silverberg JI, Choi J, Pro B, Pincus LB, Guitart J, Zhou XA. Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients. J Am Acad Dermatol. 2020;83(1):197–9. https://doi.org/10.1016/j.jaad.2020.03.050. (Epub 2020 Mar 27. PMID: 32229275; PMCID: PMC7302979).

Article  CAS  Google Scholar 

Hollins LC, Wirth P, Fulchiero GJ, Foulke GT. Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma. Cutis. 2020;106(2):E8–11.

Article  Google Scholar 

Miyashiro D, Vivarelli AG, Gonçalves F, Cury-Martins J, Sanches JA. Progression of mycosis fungoides after treatment with dupilumab: a case report. Dermatol Ther. 2020;33(6):e13880.

Article  Google Scholar 

Tran J, Morris L, Vu

留言 (0)

沒有登入
gif